Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Accumulated Depreciation: 2023-2024

Historic Accumulated Depreciation for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $156,000.

  • Upstream Bio's Accumulated Depreciation rose 168.22% to $287,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $287,000, marking a year-over-year increase of 168.22%. This contributed to the annual value of $156,000 for FY2024, which is 132.84% up from last year.
  • Per Upstream Bio's latest filing, its Accumulated Depreciation stood at $156,000 for FY2024, which was up 132.84% from $67,000 recorded in FY2023.
  • In the past 5 years, Upstream Bio's Accumulated Depreciation ranged from a high of $156,000 in FY2024 and a low of $67,000 during FY2023.
  • Its 2-year average for Accumulated Depreciation is $111,500, with a median of $111,500 in 2023.
  • Data for Upstream Bio's Accumulated Depreciation shows a peak YoY surged of 132.84% (in 2024) over the last 5 years.
  • Upstream Bio's Accumulated Depreciation (Yearly) stood at $67,000 in 2023, then surged by 132.84% to $156,000 in 2024.